FUSIONSPROTEIN MIT POLYPEPTID DAS DIE HALBWERTSZEIT VERLÄNGERT

Patent europeic · EP3642338 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3642338
Numer da la dumonda
EP18717624
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
16-04-2018
Publitgà
29-04-2020
Concedì
27-04-2022
La protecziun finescha il pli tard
15-04-2038
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
C12N 9/20 (2006.01)
Prioritad
EP 17176543 19.06.2017
Dumonda PCT
PCT/EP2018/059677 16.04.2018
Publicaziun PCT
WO2018/233895 27.12.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2026

    Midada

    Published in Swissreg on 01.05.2026

  2. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  3. 01-05-2024

    Midada

    Published in Swissreg on 01.05.2024

  4. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  5. 08-03-2023

    Midada

    Published in Swissreg on 08.03.2023

  6. 31-05-2022

    Represchentant inscrit

    Representative
    AWA Switzerland Ltd., Case Postale 2243, 2800 Delémont 2

    Published in Swissreg on 31.05.2022

  7. 27-04-2022

    Concedì

    Published in Swissreg on 27.04.2022

Partidas

Possessur

Swedish Orphan Biovitrum AB (publ)

112 76 Stockholm, SE

Inventur

SVENSSON GELIUS, Stefan

125 53 Älvsjö, SE

NORDLING, Erik

182 35 Danderyd, SE

NILSSON, Joakim

182 52 Danderyd, SE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.